Top compounds associated with response to TBC1D16


Feature Type Standardized
Nominal ANOVA
mRNA DBeQ CTRPv2 pan-cancer AAC -0.0062 0.9
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.005 0.9
mRNA KIN001-236 GDSC1000 pan-cancer AAC 0.0061 0.9
mRNA ML083 CTRPv2 pan-cancer AAC 0.0065 0.9
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0058 0.9
mRNA Carboplatin CTRPv2 pan-cancer AAC -0.006 0.9
mRNA SJ-172550 CTRPv2 pan-cancer AAC -0.0063 0.9
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.9
mRNA PD-0332991 CCLE pan-cancer AAC 0.0086 0.9
mRNA RO-3306 GDSC1000 pan-cancer AAC 0.0058 0.9
Download CSV